CompoAtlas

Dexiderm CD

Natural health product licensed in Canada

Licence holder
Cipher Pharmaceuticals Inc.
NPN or DIN-HM
80072257
Status
Active licence
Licence date
25 August 2016
Revision date
Not provided
Form
Crème
Route of administration
Topique
Application type
Non traditionnelle

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
3-Pyridinecarboxamide

Source : Niacinamide

4 % (p/p)

Non-medicinal ingredients

Caprylate de glycéryle, Alcool benzylique, Glycérol, Eau purifiée, Paraffine liquide légère, Cétostéaryl sulfate de sodium, Alcool cétostéarylique

PopulationAgeQuantity per servingFrequency
AdultesNot specified1 Crème2 Tous les jours

Uses authorised in Canada

Helps in the management and relief of the signs and symptoms of contact dermatitis (such as erythema, scaling and pruritus).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80072257

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line